Skip to main content
. 2017 Nov 18;8(62):105957–105970. doi: 10.18632/oncotarget.22515

Figure 5. Overall survival in pediatric HL patients based on therapeutic grouping.

Figure 5

Cox regression analysis showing OS in pediatric HL patients (n=113) based on therapeutic grouping (GR). As shown, GR1-C/C and GR2- C/C patients show higher EFS than GR3-C/C and GR123-C/A patients.